Lack of gender effect on ciprofloxacin pharmacokinetics in humansGALLICANO, K; SAHAI, J.British journal of clinical pharmacology. 1996, Vol 42, Num 5, pp 632-634, issn 0306-5251Conference Paper

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related TuberculosisBURMAN, W. J; GALLICANO, K; PELOQUIN, C et al.Clinical infectious diseases. 1999, Vol 28, Num 3, pp 419-430, issn 1058-4838Conference Paper

A review of low-dose ritonavir in protease inhibitor combination therapyCOOPER, C. L; VAN HEESWIJK, R. P. G; GALLICANO, K et al.Clinical infectious diseases. 2003, Vol 36, Num 12, pp 1585-1592, issn 1058-4838, 8 p.Article

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infectionSAHAI, J; GALLICANO, K; SWICK, L et al.Annals of internal medicine. 1997, Vol 127, Num 4, pp 289-293, issn 0003-4819Article

Decreased HIV-associated T cell apoptosis by HIV protease inhibitorsPHENIX, B. N; ANGEL, J. B; BADLEY, A. D et al.AIDS research and human retroviruses. 2000, Vol 16, Num 6, pp 559-567, issn 0889-2229Article

Lake Louise consensus conference on cyclosporin monitoring in organ transplantation : report of the consensus panelOELLERICH, M; ARMSTRONG, V. W; SCHÜTZ, E et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 642-654, issn 0163-4356Conference Paper

Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver diseaseKHALLQ, Y; GALLICANO, K; SEGUIN, I et al.British journal of clinical pharmacology. 2000, Vol 50, Num 2, pp 108-115, issn 0306-5251Article

Effect of bismuth subsalicylate on ciprofloxacin bioavailabilityRAMBOUT, L; SAHAI, J; GALLICANO, K et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 9, pp 2187-2190, issn 0066-4804Article

Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virusSAHAI, J; GALLICANO, K; GARBER, G et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 5, pp 464-470, issn 0009-9236Article

Generic drugs : The Canadian perspectiveMCGILVERAY, I. J; GALLICANO, K.Transplantation proceedings. 1999, Vol 31, Num 3A, pp 16S-18S, issn 0041-1345, SUPConference Paper

Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virusGALLICANO, K; SAHAI, J; SWICK, L et al.Clinical infectious diseases. 1995, Vol 21, Num 4, pp 1008-1011, issn 1058-4838Article

Effects of the antacids in didanosine tablets on dapsone pharmacokineticsSAHAI, J; GARBER, G; GALLICANO, K et al.Annals of internal medicine. 1995, Vol 123, Num 8, pp 584-587, issn 0003-4819Article

Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patientsJAN SAHAI; GALLICANO, K; GARBER, G et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1995, Vol 10, Num 1, pp 54-60, issn 1077-9450Article

The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patientsSAHAI, J; GALLICANO, K; GARBER, G et al.British journal of clinical pharmacology. 1992, Vol 33, Num 6, pp 657-660, issn 0306-5251Article

Effect of ciproflaxacin on the disposition of ¹⁴C-dideoxyinosine-derived radioactivity in the ratGALLICANO, K. D; BUTTAR, H. S; HOFFATT, J. H et al.Research communications in chemical pathology and pharmacology. 1993, Vol 80, Num 2, pp 163-174, issn 0034-5164Article

Disintegration of dextran sulfate tablet products : effect of physicochemical propertiesNEVILLE, G. A; GALLICANO, K. D; BECKSTEAD, H. D et al.Drug development and industrial pharmacy. 1992, Vol 18, Num 19, pp 2067-2079, issn 0363-9045Article

Preparation and crystal and molecular structure of (η³-nonamethylcyclotetraphosphazanium-P,P,P)tricarbonylmolybdenum(O) iodide-acetonitrile (1:1), [η³-Me(MeNPMe)₄Mo(CO)₃[I•MeCNGALLICANO, K. D; PADDOCK, N. L; RETTIG, S. J et al.Canadian journal of chemistry (Print). 1984, Vol 62, Num 9, pp 1869-1873, issn 0008-4042Article

Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patientsGALLICANO, K. D; SAHAI, J; SHUKLA, V. K et al.British journal of clinical pharmacology. 1999, Vol 48, Num 2, pp 168-179, issn 0306-5251Article

Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD)GALLICANO, K. D; TOBE, S; SAHAI, J et al.Journal of acquired immune deficiency syndromes. 1992, Vol 5, Num 3, pp 242-250, issn 0894-9255Article